These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28156159)

  • 1. Cholesterol-PEG comodified poly (N-butyl) cyanoacrylate nanoparticles for brain delivery: in vitro and in vivo evaluations.
    Hu X; Yang F; Liao Y; Li L; Zhang L
    Drug Deliv; 2017 Nov; 24(1):121-132. PubMed ID: 28156159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel-Loaded Cholesterol-PEG Co-Modified Poly (n-Butyl) Cyanoacrylate Nanoparticles for Antitumor Drug Pulmonary Delivery: Preparation, Characterization, and in vivo Evaluation.
    Hu X; Yang F; Liao Y; Li L; Zhao G; Zhang L
    Int J Nanomedicine; 2020; 15():5361-5376. PubMed ID: 32801694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency.
    Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X
    Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of phospholipid and polyethylene glycol monostearate (100) on the in vitro and in vivo physico-chemical characterization of poly(n-butyl cyanoacrylate) nanoparticles.
    Jin X; Asghar S; Zhang M; Chen Z; Zhang J; Ping Q; Xiao Y
    Colloids Surf B Biointerfaces; 2019 Jan; 173():320-326. PubMed ID: 30312943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations.
    Hu K; Li J; Shen Y; Lu W; Gao X; Zhang Q; Jiang X
    J Control Release; 2009 Feb; 134(1):55-61. PubMed ID: 19038299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.
    Geldenhuys W; Wehrung D; Groshev A; Hirani A; Sutariya V
    Pharm Dev Technol; 2015 Jun; 20(4):497-506. PubMed ID: 24597667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
    Gan CW; Feng SS
    Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of 10-hydroxycamptothecin-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization.
    Jin X; Asghar S; Zhu X; Chen Z; Tian C; Yin L; Ping Q; Xiao Y
    Colloids Surf B Biointerfaces; 2018 Feb; 162():25-34. PubMed ID: 29145001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides.
    Li J; Feng L; Fan L; Zha Y; Guo L; Zhang Q; Chen J; Pang Z; Wang Y; Jiang X; Yang VC; Wen L
    Biomaterials; 2011 Jul; 32(21):4943-50. PubMed ID: 21470674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
    Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.
    Bi C; Wang A; Chu Y; Liu S; Mu H; Liu W; Wu Z; Sun K; Li Y
    Int J Nanomedicine; 2016; 11():6547-6559. PubMed ID: 27994458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The brain targeting mechanism of Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles.
    Xin H; Sha X; Jiang X; Chen L; Law K; Gu J; Chen Y; Wang X; Fang X
    Biomaterials; 2012 Feb; 33(5):1673-81. PubMed ID: 22133551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery.
    Lu W; Zhang Y; Tan YZ; Hu KL; Jiang XG; Fu SK
    J Control Release; 2005 Oct; 107(3):428-48. PubMed ID: 16176844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein delivery nanosystem of six-arm copolymer poly(ε-caprolactone)-poly(ethylene glycol) for long-term sustained release.
    Duan J; Liu C; Liang X; Li X; Chen Y; Chen Z; Wang X; Kong D; Li Y; Yang J
    Int J Nanomedicine; 2018; 13():2743-2754. PubMed ID: 29780245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparative Study of Orally Delivered PBCA and ApoE Coupled BSA Nanoparticles for Brain Targeting of Sumatriptan Succinate in Therapeutic Management of Migraine.
    Girotra P; Singh SK
    Pharm Res; 2016 Jul; 33(7):1682-95. PubMed ID: 27003706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
    Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
    J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
    Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y
    Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of poly(ethylene glycol) coating and monomer type on poly(alkyl cyanoacrylate) nanoparticle interactions with lipid monolayers and cells.
    Baghirov H; Melikishvili S; Mørch Y; Sulheim E; Åslund AKO; Hianik T; de Lange Davies C
    Colloids Surf B Biointerfaces; 2017 Feb; 150():373-383. PubMed ID: 27842930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.